| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 02/18/2003 | US6521265 Mixing anhydrous ferrate (VI) salt which hydrates to produce Fe+3 with blood flowing from a wound or water to form a paste; applying paste to the wound; K2FeO4 becomes FeOOH in water, which upon drying, yields ultrafine Fe2O3 |
| 02/18/2003 | US6521249 Feedstock for prepartum dairy cattle |
| 02/18/2003 | US6521243 Ionic chitosan -iodine complexes: antiseptic hydrogels and wound healing promoters |
| 02/18/2003 | CA2215093C Method of treating domestic animals such as cows for mastitis and apparatus for injecting ozone into breasts |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003011345A1 Lipid constructs as therapeutic and imaging agents |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011309A2 Pharmaceutical composition for treating hypercholesterolaemia |
| 02/13/2003 | WO2003011305A1 Composition of glycosaminoglycan and a peroxide for the treatment of dry eye |
| 02/13/2003 | WO2003011303A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 02/13/2003 | WO2003011275A1 Swine growth promoters and method of promoting swine growth |
| 02/13/2003 | WO2003011251A1 Pulmonary formulation |
| 02/13/2003 | WO2003011033A1 Microbiological control in animal processing |
| 02/13/2003 | WO2002080849A3 Chemotherapeutic induction of egr-1 promoter activity |
| 02/13/2003 | WO2002078644A3 Use of ozone for the treatment of dental and oral conditions |
| 02/13/2003 | WO2002051388A3 Treatment of inoperable tumors by stereotactic injection of microspheres |
| 02/13/2003 | US20030032943 Biocompatible, injectable aqueous solution for use in ultrasound energy assisted surgery |
| 02/13/2003 | US20030032636 For the treatment of depression and other affective disorders. |
| 02/13/2003 | US20030031730 Nasal passage cleaning composition |
| 02/13/2003 | US20030031728 A polymer compounded with a silver ion-emitting additive. e.g. a silver or silver zinc zeolite; located on the interior of the tube; catheters; dental instrument, soda and drinking fountains, refrigerators; sanitation |
| 02/13/2003 | US20030031727 A water-soluble divalent strontium cation in a suitable topical formulation vehicle; preferably, strontium nitrate, strontium chloride and strontium acetate; cosmetics; drugs soaps; detergents; antiallergens |
| 02/13/2003 | US20030031726 Calcium dietary supplement |
| 02/13/2003 | US20030031725 Specified mineral salts and catalyst-altered water in an aqueous solution and may also contain ethanol; corrects mineral imbalances |
| 02/13/2003 | US20030031694 Controlled release particles |
| 02/13/2003 | DE20214761U1 Alkaline gel useful for drawing out excess acids from body, comprising distilled water, sodium bicarbonate, pentylene glycol and usnea barbata |
| 02/13/2003 | CA2455598A1 Lipid constructs as therapeutic and imaging agents |
| 02/13/2003 | CA2454937A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | CA2454066A1 Pulmonary formulation |
| 02/12/2003 | EP1282631A1 Methods of synthesis and use of radiolabelled platinum chemotherapeutic agents |
| 02/12/2003 | EP1282436A2 Treatment of acute coronary syndrome with glp-1 |
| 02/12/2003 | EP1282429A1 Pharmaceutical gel composition |
| 02/12/2003 | EP1282426A1 Nutritional preparation comprising ribose and folic acid and medical use thereof |
| 02/12/2003 | EP1282391A2 High cleaning dentifrice |
| 02/12/2003 | EP1282365A2 Preparation for the prevention and/or treatment of vascular disorders |
| 02/12/2003 | EP1109534B1 Quick release pharmaceutical compositions of drug substances |
| 02/12/2003 | EP0820292B1 Inhibition of c. difficile infections by indigestible oligosaccharides |
| 02/12/2003 | CN1396822A Liposomes containing entrapped compound in supersaturated solution |
| 02/12/2003 | CN1395964A Medical usage of simonder wood oil |
| 02/12/2003 | CN1395959A Eyedrops 'Yanbijing' |
| 02/12/2003 | CN1395948A Medicine 'Bixueling' for treating epistaxis |
| 02/12/2003 | CN1395943A Disinfecting liniment and its preparing process |
| 02/12/2003 | CN1101209C Medicine for treaitng digestive tract diseases |
| 02/12/2003 | CN1101208C Medicine for treating uninary calculaus and its preparing process |
| 02/12/2003 | CN1101193C Agent for reducing nephrotoxicity due to medicine |
| 02/11/2003 | US6518416 Method of determining a chemotherapeutic regimen based on ERCC1 expression |
| 02/11/2003 | US6518310 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant |
| 02/11/2003 | US6518307 Orally administering an effective amount of a peracid to an animal. |
| 02/11/2003 | US6518278 Administering a synergistically effective amount of irinotecane and subsequently with a synergistically effective amount of cis-oxalato (1R,2R-diaminocyclohexane) Pt (II) |
| 02/11/2003 | US6518247 Method for producing an antitumoral agent and antitumoral agent thus obtained |
| 02/11/2003 | US6517819 Antiperspirant suspensions containing finely divided aluminium and zirconium, having better effectiveness and a process for their manufacture |
| 02/11/2003 | US6517810 Palliation of bone pain due to cancer by the administration of a tin stannic (Sn+4) chelate complex |
| 02/11/2003 | US6517795 Process for producing hydrotalcites and the metal oxides thereof |
| 02/11/2003 | CA2151564C Monomeric insulin analog formulations |
| 02/06/2003 | WO2003009877A1 Topical pharmaceutical formulation |
| 02/06/2003 | WO2003009846A1 Novel substituted benzimidazole dosage forms and method of using same |
| 02/06/2003 | WO2003009807A2 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/06/2003 | WO2003009802A2 Synergistic antimicrobial ophthalmic and dermatologic preparations containing chlorite and hydrogen peroxide |
| 02/06/2003 | WO2002080940A3 Pharmacologically active strong acid solutions |
| 02/06/2003 | WO2002062355A3 Hydriodic acid and iodide salts for treatment of male impotence |
| 02/06/2003 | WO2002056826A3 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 02/06/2003 | WO2001066139A9 Use of a compound that selectively binds to cd123 to impair hematologic cancer progenitor cell |
| 02/06/2003 | US20030027848 Stabilized formulations |
| 02/06/2003 | US20030027844 Component a): one or more conventional anti-ulcer products; component b): organic compounds containing the -ONO2 function, or inorganic compounds containing the -NO group, that are nitric oxide donors |
| 02/06/2003 | US20030027817 Combination therapy for treatment of bipolar disorders |
| 02/06/2003 | US20030027808 Imidazoly-5-yl)methyl-2-quinolinone derivatives, together with platinum coordination compound selected from cisplatin or carboplatin; useful as anticarcinogenic agent |
| 02/06/2003 | US20030027799 As anticancer agents |
| 02/06/2003 | US20030027211 Fetuin-MGP-mineral complex in serum |
| 02/06/2003 | US20030026860 Administering calcium compoound and fat blend |
| 02/06/2003 | US20030026853 Method and composition for treatment of inflammatory and inflammation-related disorders |
| 02/06/2003 | US20030026852 Molecular iodine pharmaceutical composition |
| 02/06/2003 | US20030026851 Mixture of plant extract and oxidation resistance compound |
| 02/06/2003 | US20030026837 Effervescent solid composition of matter |
| 02/06/2003 | CA2452159A1 Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods |
| 02/05/2003 | EP1281702A2 Calcium receptor active molecules |
| 02/05/2003 | EP1281401A2 The medical effect of Jojoba oil |
| 02/05/2003 | EP1280735A2 Precipitated aragonite and a process for producing it |
| 02/05/2003 | EP1280734A2 Salt comprising more than 95 wt. % of sodium chloride, use and preparation method thereof and method for measuring salt water content |
| 02/05/2003 | EP1280567A2 Nitric oxide-releasing metallic medical devices |
| 02/05/2003 | EP1280557A1 Method for the preparation of polymeric micelle via phase separation of block copolymer |
| 02/05/2003 | EP1280538A2 Compositions containing molecular iodine |
| 02/05/2003 | EP0841904B1 Oral pharmaceutical compositions with delayed release of reversible proton pump inhibitors |
| 02/05/2003 | EP0794787B1 Compositions for the treatment of parasitic and fungal infections |
| 02/05/2003 | CN1395489A Physiologically balanced ionized acidic solution and methodology for use in wound healing |
| 02/05/2003 | CN1394649A Ending vascular embolism preparation |
| 02/05/2003 | CN1394644A Shenhong capsule with actions of removing blood stasis and obstruction |
| 02/05/2003 | CN1394631A Health-care food for resisting fatigue |
| 02/05/2003 | CN1394611A Arsenic trioxide (ATO) oral slow-releasing granules and its preparation method |
| 02/05/2003 | CN1100552C Medicine for curing hemiparalysis |
| 02/05/2003 | CN1100549C Preparation of external-use Chinese medicine for curing chapped skin and chapped eczema |
| 02/05/2003 | CN1100544C Mercury chloride injection |
| 02/05/2003 | CN1100543C 聚维酮碘膜剂 Povidone iodine agent |
| 02/04/2003 | US6515016 Treating or preventing multiple sclerosis, by administering an antimicrotubule agent; treating various other inflammatory diseases |
| 02/04/2003 | US6514960 Use of bismuth subgallate in inhibition of production of nitric oxide synthase |
| 02/04/2003 | US6514537 Citric acid, magnesium hydroxide, water |
| 02/04/2003 | US6514489 Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
| 02/04/2003 | US6514484 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces using an integral carrier |
| 02/04/2003 | CA2169019C Improvements in platinum complexes |
| 02/04/2003 | CA2122612C Pharmaceutical products for curing tumourous diseases and process for preparing same |
| 01/30/2003 | WO2003007970A2 Use of magnesium for preventing in-stent thrombosis and complications after arterial angioplasty with stent placement |
| 01/30/2003 | WO2003007931A1 Sulfonamide derivatives |